Skip to main content
Amiko M. Uchida
( out of 25 reviews )

Amiko M. Uchida, MD

  • CLINICAL:

    Amiko Uchida, MD is a gastroenterologist at the University of Utah School of Medicine and specializes in caring for and conducting research focused on patients with immune disorders of the GI tract, such as eosinophilic GI disease (EGID) and inflammatory bowel diseases (IBD). Dr. Uchida is a Utah-native and obtained her medical degree from the University of Utah before going on to train in internal medicine at the University of Washington and gastroenterology at Massachusetts General Hospital, where she also completed EGID and IBD training.

    She has particular interest and expertise in the increasingly common, yet poorly understood disease called eosinophilic esophagitis (EoE) as well as other eosinophilic gastrointestinal diseases. She is the Co-Director of the University of Utah Multidisciplinary Eosinophilic Gastrointestinal Disease Clinic, which is one of approximately five clinics of its type in the United States.

    Dr. Uchida’s other academic interests include the advancement of women in medicine and science and physician well-being and heads the Women in Gastroenterology Council. In her free time, she loves spending time in the great outdoors with her family. They particularly enjoy hiking, biking, and skiing.

    RESEARCH:

    Amiko Uchida, MD is a basic and translational physician-scientist gastroenterologist at the University of Utah School of Medicine where she also obtained her medical degree. She trained in gastroenterology at Massachusetts General Hospital and completed her post-doctoral work in the laboratories of John Garber MD and Stephanie and Michael Dougan, PhD and MD PhD, respectively. Dr. Uchida’s clinical and research interests include immune disorders of the GI tract, such as eosinophilic GI diseases and inflammatory bowel diseases. In addition to being co-Clinical Director of the Eosinophilic GI Disease Clinic, she is the Director of the Gastrointestinal Biobank, which connects basic scientists with clinicians and patient biospecimens to better understand health and disease.

    She currently working with co-mentor June Round PhD and Kathryn Peterson, MD MSCI investigating the increasingly common, yet poorly understood disease called eosinophilic esophagitis (EoE) and other EGIDs. She focuses on signaling mechanisms of disease pathology, the microbiota, and therapeutic options for patients suffering from EoE. More specifically, her research program encompasses better defining how diet and the microbiome affect inflammation in EoE and what non-invasive markers or testing can be performed to manage the disease.

    Please navigate to the Clinical Trials tab for some of the research opportunities as a part of our growing program.

    Board Certification

    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Gastroenterology)

    Patient Rating

    4.9 /5
    ( out of 25 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

  • CLINICAL:

    Amiko Uchida, MD is a gastroenterologist at the University of Utah School of Medicine and specializes in caring for and conducting research focused on patients with immune disorders of the GI tract, such as eosinophilic GI disease (EGID) and inflammatory bowel diseases (IBD). Dr. Uchida is a Utah-native and obtained her medical degree from the University of Utah before going on to train in internal medicine at the University of Washington and gastroenterology at Massachusetts General Hospital, where she also completed EGID and IBD training.

    She has particular interest and expertise in the increasingly common, yet poorly understood disease called eosinophilic esophagitis (EoE) as well as other eosinophilic gastrointestinal diseases. She is the Co-Director of the University of Utah Multidisciplinary Eosinophilic Gastrointestinal Disease Clinic, which is one of approximately five clinics of its type in the United States.

    Dr. Uchida’s other academic interests include the advancement of women in medicine and science and physician well-being and heads the Women in Gastroenterology Council. In her free time, she loves spending time in the great outdoors with her family. They particularly enjoy hiking, biking, and skiing.

    RESEARCH:

    Amiko Uchida, MD is a basic and translational physician-scientist gastroenterologist at the University of Utah School of Medicine where she also obtained her medical degree. She trained in gastroenterology at Massachusetts General Hospital and completed her post-doctoral work in the laboratories of John Garber MD and Stephanie and Michael Dougan, PhD and MD PhD, respectively. Dr. Uchida’s clinical and research interests include immune disorders of the GI tract, such as eosinophilic GI diseases and inflammatory bowel diseases. In addition to being co-Clinical Director of the Eosinophilic GI Disease Clinic, she is the Director of the Gastrointestinal Biobank, which connects basic scientists with clinicians and patient biospecimens to better understand health and disease.

    She currently working with co-mentor June Round PhD and Kathryn Peterson, MD MSCI investigating the increasingly common, yet poorly understood disease called eosinophilic esophagitis (EoE) and other EGIDs. She focuses on signaling mechanisms of disease pathology, the microbiota, and therapeutic options for patients suffering from EoE. More specifically, her research program encompasses better defining how diet and the microbiome affect inflammation in EoE and what non-invasive markers or testing can be performed to manage the disease.

    Please navigate to the Clinical Trials tab for some of the research opportunities as a part of our growing program.

  • News & Podcasts